Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 10/9/2025

Imaging for Recurrent High-Grade Serous Carcinoma at 6 Months

Rationale for Comprehensive Restaging

  • The European Society for Medical Oncology (ESMO) guidelines recommend full re-staging including bone imaging in patients with recurrence, given the high risk of concomitant distant metastases 1, 2
  • The standard approach for recurrent disease involves thoracic and abdominal CT as the preferred modality over plain radiography 1

Bone Metastasis Screening Strategy

  • Symptomatic patients should undergo bone scintigraphy or radiography if they have signs and symptoms of bone metastases, including localized bone pain 3, 1
  • Elevated bone-specific alkaline phosphatase (B-ALP) suggests bone involvement and warrants consideration of bone imaging 3, 4
  • Patients with aggressive tumor biology warrant consideration of bone imaging 1, 4

Optimal Imaging Approach for HGSC Recurrence

  • Contrast-enhanced CT of chest, abdomen, and pelvis is the cornerstone for restaging 1, 2
  • PET/CT with 18FDG may be used instead of CT and bone scintigraphy when conventional methods are inconclusive 1, 2

Clinical Algorithm

  • For asymptomatic recurrence at 6 months, obtain contrast-enhanced CT chest/abdomen/pelvis as primary restaging tool 1, 2
  • If symptomatic or biochemical evidence exists, add bone scintigraphy or consider PET/CT 3, 1
  • For symptomatic recurrence, full restaging with contrast-enhanced CT chest/abdomen/pelvis and bone-specific imaging (bone scan, PET/CT, or MRI) is recommended 1, 2, 3, 1

Important Caveats

  • Bone scintigraphy has lower cost and greater availability than PET/CT or whole-body MRI, but inferior sensitivity for early or small metastases 3, 1